Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-01-02

Clinical Trial Update: A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder [Phase 3]

View source ↗

Summary

Phase 3 trial comparing brexpiprazole to placebo for acute manic episodes in Bipolar I Disorder has completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • brexpiprazole (brexpiprazole)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Bipolar I Disorder, Manic Episode | Phase 3 | Status: COMPLETED | Results posted: 2020-01-02